Molecular Profile | Unknown unknown |
Therapy | CFI-400936 |
Indication/Tumor Type | colon cancer |
Response Type | not applicable |
Create By | smockus |
Update By | c-romase |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | colon cancer | not applicable | CFI-400936 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, CFI-400936 inhibited tumor growth in a human cell line xenograft model of colon cancer (PMID: 25043312). | 25043312 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(25043312) | Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides. | Full reference... |